相似文献
1
Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.
J Med Chem. 2009 Apr 9;52(7):1873-84. doi: 10.1021/jm801335z.
2
Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Bioorg Med Chem. 2010 Jul 15;18(14):5352-66. doi: 10.1016/j.bmc.2010.05.042. Epub 2010 May 24.
3
Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.
J Med Chem. 2012 Jan 12;55(1):367-77. doi: 10.1021/jm201251c. Epub 2011 Dec 29.
4
Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Int J Biol Macromol. 2012 May 1;50(4):1127-32. doi: 10.1016/j.ijbiomac.2012.02.006. Epub 2012 Feb 15.
5
Synthesis of carbon-11-labeled casimiroin analogues as new potential PET agents for imaging of quinone reductase 2 and aromatase expression in breast cancer.
Steroids. 2010 Dec;75(12):967-73. doi: 10.1016/j.steroids.2010.06.004. Epub 2010 Jun 15.
6
Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis.
J Med Chem. 2007 Jan 25;50(2):350-5. doi: 10.1021/jm060915+.
7
Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
Anticancer Agents Med Chem. 2024;24(4):288-303. doi: 10.2174/0118715206265278231026101739.
8
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
ChemMedChem. 2010 Sep 3;5(9):1577-93. doi: 10.1002/cmdc.201000203.
9
Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
Bioorg Med Chem Lett. 2017 Dec 15;27(24):5393-5399. doi: 10.1016/j.bmcl.2017.11.010. Epub 2017 Nov 6.
10
Novel aromatase inhibitors by structure-guided design.
J Med Chem. 2012 Oct 11;55(19):8464-76. doi: 10.1021/jm300930n. Epub 2012 Sep 24.
引用本文的文献
1
Advantages and Disadvantages of Two Assays in Evaluating Aromatase Activity: "A Cell-Based and a Cell-Free Assay".
Turk J Pharm Sci. 2022 Dec 21;19(6):626-629. doi: 10.4274/tjps.galenos.2021.85530.
2
Design, Synthesis, and Biological Evaluation of 1,2,4-Thiadiazole-1,2,4-Triazole Derivatives Bearing Amide Functionality as Anticancer Agents.
Arab J Sci Eng. 2021;46(1):225-232. doi: 10.1007/s13369-020-04626-z. Epub 2020 May 22.
3
Synthesis of Mono--Methyl Aromatic Amines from Nitroso Compounds and Methylboronic Acid.
ACS Omega. 2019 Aug 12;4(9):13943-13953. doi: 10.1021/acsomega.9b01608. eCollection 2019 Aug 27.
4
Gold-catalyzed post-Ugi alkyne hydroarylation for the synthesis of 2-quinolones.
Beilstein J Org Chem. 2018 Oct 4;14:2572-2579. doi: 10.3762/bjoc.14.234. eCollection 2018.
5
Dirhodium-catalyzed C-H arene amination using hydroxylamines.
Science. 2016 Sep 9;353(6304):1144-7. doi: 10.1126/science.aaf8713.
6
Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.
J Med Chem. 2016 Jun 9;59(11):5131-48. doi: 10.1021/acs.jmedchem.5b01281. Epub 2016 Jan 19.
7
Spongiapyridine and related spongians isolated from an Indonesian Spongia sp.
J Nat Prod. 2014 Jul 25;77(7):1644-9. doi: 10.1021/np500256w. Epub 2014 Jul 3.
8
An efficient method for the construction of polysubstituted 4-pyridones via self-condensation of β-keto amides mediated by P2O5 and catalyzed by zinc bromide.
Beilstein J Org Chem. 2013 Nov 28;9:2681-7. doi: 10.3762/bjoc.9.304. eCollection 2013.
9
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.
Bioorg Med Chem. 2014 Jan 1;22(1):126-34. doi: 10.1016/j.bmc.2013.11.045. Epub 2013 Dec 5.
10
Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.
Bioorg Med Chem. 2013 Oct 1;21(19):6022-37. doi: 10.1016/j.bmc.2013.07.037. Epub 2013 Jul 27.
本文引用的文献
1
Quinone reductase 2 is a catechol quinone reductase.
J Biol Chem. 2008 Aug 29;283(35):23829-35. doi: 10.1074/jbc.M801371200. Epub 2008 Jun 24.
2
Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.
Biochem J. 2008 Jul 1;413(1):81-91. doi: 10.1042/BJ20071373.
3
Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer.
J Med Chem. 2007 Jun 14;50(12):2799-806. doi: 10.1021/jm070109i. Epub 2007 May 19.
4
Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
Br J Cancer. 2006 Nov 6;95(9):1229-33. doi: 10.1038/sj.bjc.6603414. Epub 2006 Oct 10.
5
NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Biochem Pharmacol. 2006 Jul 28;72(3):366-76. doi: 10.1016/j.bcp.2006.04.029. Epub 2006 May 4.
6
Miliusanes, a class of cytotoxic agents from Miliusa sinensis.
J Med Chem. 2006 Jan 26;49(2):693-708. doi: 10.1021/jm0509492.
7
NRH:quinone reductase 2: an enzyme of surprises and mysteries.
Biochem Pharmacol. 2005 Dec 19;71(1-2):1-12. doi: 10.1016/j.bcp.2005.09.019. Epub 2005 Oct 25.
8
Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954.
Biochem Biophys Res Commun. 2005 Oct 14;336(1):332-8. doi: 10.1016/j.bbrc.2005.08.081.
9
Molecular tools to study melatonin pathways and actions.
Trends Pharmacol Sci. 2005 Aug;26(8):412-9. doi: 10.1016/j.tips.2005.06.006.
10
Quinone reductase 2 substrate specificity and inhibition pharmacology.
Chem Biol Interact. 2005 Feb 10;151(3):213-28. doi: 10.1016/j.cbi.2005.01.002.
Zotero 插件